Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 74

Results For "medicines"

1419 News Found

Dr. Reddy's appoints Sunil Gavaskar as the brand ambassador for its #TensionMatLo campaign
Healthcare | August 21, 2023

Dr. Reddy's appoints Sunil Gavaskar as the brand ambassador for its #TensionMatLo campaign

The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle


Healthcare is not just a sector, but a mission: Dr. Mansukh Mandaviya
Policy | August 21, 2023

Healthcare is not just a sector, but a mission: Dr. Mansukh Mandaviya

With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility


India's Medical Value sector projected to reach $ 13 billion by 2026: Dr Mandaviya
Policy | August 18, 2023

India's Medical Value sector projected to reach $ 13 billion by 2026: Dr Mandaviya

Need to harmonize traditional and modern medicine to combat alarming health problems


Health Minister Mandaviya inaugurates the phase II of Mass Drug Administration initiative for Lymphatic Filariasis
Public Health | August 12, 2023

Health Minister Mandaviya inaugurates the phase II of Mass Drug Administration initiative for Lymphatic Filariasis

India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive


Dimensionless Technologies launches AushadhAI to support pharma supply chain
Digitisation | August 12, 2023

Dimensionless Technologies launches AushadhAI to support pharma supply chain

AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents


Mandaviya addresses BRICS Health Minister’s meeting
News | August 09, 2023

Mandaviya addresses BRICS Health Minister’s meeting

Reiterates India’s commitment to the BRICS TB Research Network Initiative


USFDA approves Merck’s ERVEBO for use in children 12 months of age and older
Drug Approval | August 05, 2023

USFDA approves Merck’s ERVEBO for use in children 12 months of age and older

Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease


Jemperli plus chemotherapy approved in the US as the first new frontline treatment option for dMMR/MSI-H primary advanced or recurrent endometrial cancer
Drug Approval | August 01, 2023

Jemperli plus chemotherapy approved in the US as the first new frontline treatment option for dMMR/MSI-H primary advanced or recurrent endometrial cancer

Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy


Fluor awarded more than $1 billion in life sciences contracts
News | August 01, 2023

Fluor awarded more than $1 billion in life sciences contracts

Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.